Major tobacco company sparks backlash after attempting to launch new product in US: 'Stay within the framework'
Summary
British American Tobacco (BAT) decided to postpone the pilot launch of its unlicensed vape product, Vuse One, amid increased scrutiny from the Food and Drug Administration (FDA) regarding unauthorized products flooding the market, many originating from China. Meanwhile, Philip Morris International (PMI), which also has non-FDA-approved nicotine pouches on the market, stated its CEO, Jacek Olczak, prefers to "stay within the framework dictated by FDA" and hopes the application process speeds up. The article also highlights the significant health risks associated with vaping, including exposure to heavy metals and carcinogens, and notes that vaping remains prevalent among US youth. Furthermore, it points out the environmental hazards posed by improperly disposed, flammable lithium-ion batteries found in single-use vapes.
(Source:The Cool Down)